학술논문

Interleukin-12 Increases Proliferation and Interferon-[gamma] Production but Not Cytolytic Activity of Human Antigen-Specific Effector Memory Cytotoxic T Lymphocytes: Power of the Effect Depends on the Functional Avidity of the T Cell and the Antigen Concentration
Document Type
Academic Journal
Source
Human Immunology. Nov, 2005, Vol. 66 Issue 11, p1137, 9 p.
Subject
Interferon gamma
T cells
Antigens
Biological response modifiers
Interleukins
Language
English
ISSN
0198-8859
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.humimm.2006.02.002 Byline: Hetty J. Bontkes, Janneke J. Ruizendaal, Duco Kramer, Chris J.L.M. Meijer, Marco W.J. Schreurs, Erik Hooijberg Keywords: avidity; cytotoxic T lymphocyte; interferon-[gamma]; interleukin-12; vaccination Abstract: Cytotoxic T lymphocytes (CTLs) play an important role in the defense against viral infections and malignant diseases. Interleukin (IL)-12 plays a crucial role in induction of antigen-specific primary CTL responses and enhances proliferation, interferon-[gamma] (IFN-[gamma]) production, and cytolytic activity of mitogen-stimulated T cells. However, the effects of IL-12 on proliferation and effector functions of previously in vitro or in vivo primed antigen-specific CTLs are less clear. Our results show that IL-12 induces an increase in proliferation of and IFN-[gamma] production by influenza peptide-specific CTLs, but no increase in cytolytic activity on a per cell basis was observed in bulk cultures. Stimulation of a CTL clone confirmed these results; IL-12 supported an increase in IFN-[gamma] production, but did not increase cytolytic activity. The extent of the effect of IL-12 on IFN-[gamma] production differs per CTL clone and depends on the avidity of the clone and the peptide concentration on its target. Our data suggest that IL-12 is a good adjuvant for boosting CTL responses, in terms of proliferation and IFN-[gamma] production, the latter particularly for CTLs with low to intermediate avidity, such as tumor-associated self-antigen-specific CTLs. Author Affiliation: Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.